Related Experiment Video
Updated: Jul 10, 2026

09:01
Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
The CSDH Grading Scheme for Middle Meningeal Artery Embolization: Stratified Risk of Surgical Rescue
Li Ma1, Rachel C Jacobs1, Prateek Agarwal1
1Department of Neurological Surgery, University of Pittsburgh Medical Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Neurosurgery
|July 9, 2026
Summary
A new CSDH score predicts surgical rescue risk after middle meningeal artery embolization (MMAE). Higher scores indicate increased risk, aiding treatment decisions for chronic subdural hematomas (CSDHs).
Area of Science:
- Neurosurgery
- Interventional Radiology
- Medical Imaging
Background:
- Chronic subdural hematomas (CSDHs) often require intervention.
- Middle meningeal artery embolization (MMAE) is an emerging treatment for CSDHs.
- Predicting the need for surgical rescue after MMAE is crucial for patient management.
Purpose of the Study:
- To develop and validate a grading scheme for predicting surgical rescue risk after MMAE in CSDH patients.
- To identify factors at presentation that indicate MMAE failure.
Main Methods:
- A 4-domain grading scheme was developed, assessing coagulation, scan findings, neurological deficits, and patient history.
- The scheme's predictive performance was evaluated using calibration curves and C-index in an institutional cohort.
- Accuracy was compared against regression models in a separate test dataset.
Main Results:
- The CSDH score demonstrated strong predictive accuracy (C-index 0.81) and discrimination.
- Surgical rescue rates increased significantly with higher CSDH scores (Grade 1: 5.4%, Grade 2: 29%, Grade 3: 67%).
- The CSDH score outperformed traditional regression models in a test dataset (AUROC 0.85).
Conclusions:
- The CSDH score effectively stratifies surgical rescue risk after MMAE.
- Comprehensive assessment of imaging, deficits, and hemorrhagic factors can guide MMAE candidacy.
- This tool can optimize patient selection and follow-up strategies for CSDH treatment.
